Suven Life Sciences Ltd, an Indian CRAMS player,  has been granted  three new patents by the European Patent Office for its research relating to neurodegenerative diseases.

Growing at compounded annual growth rate of nearly 14% in the next few years, the Indian pharmaceutical market is expected to touch USD 40 billion by 2015, predicts  the global management consulting major  Mckinsey and Company.

PV-10, an experimaental drug by Provectus Pharmaceuticals, to treat metastatic melanoma, has shown to be increasing the overall survival rate in patients.

Serum Institute, Panacea Biotech and Bharat Biotech are expected to launch human studies of their H1N1 swine flu vaccine candidates in India by early next year.